Stock Screener App

Gratuito -

1.75

1.13% -0.02

I-Mab ADR (IMAB)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione

I-Mab ADR Borsa (IMAB) Ultime notizie

(IMAB) - Analyzing I-MAB's Short Interest By Benzinga - Investing.com UK

Investing.com UK

Here's Why IMab Sponsored ADR (IMAB) is Poised for a Turnaround After Losing 26.8% in 4 Weeks - Yahoo Lifestyle UK

Yahoo Lifestyle UK

Patent Law Changes Pose Threat to I-Mab Adr's Drug Candidate Protection - TipRanks.com - TipRanks

I-Mab Announces CMO Transition, Interim Successor Named - TipRanks.com - TipRanks

I-Mab Finalizes Divestiture and Resolves Obligations - TipRanks.com - TipRanks

NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Piper Sandler cuts I-Mab stock target to $10, keeps overweight rating - Investing.com

IMAB Stock Quote Price and Forecast - CNN

Minnelide combined with anti-ANGPTL3-FLD monoclonal antibody completely protects mice with adriamycin ... - Nature.com

I-Mab Provides Business and Corporate Updates and Reports Financial Results for the Year Ended December 31, 2022 - PR Newswire

Morningstar's Best- and Worst-Performing Stocks: 2022 - Morningstar

The Cheapest Stock in the World - Morningstar.ca

10 of the Cheapest Stocks of 2022 - Morningstar

Why Are Some China Healthcare Stocks Up 50%? - Morningstar HK

Le 1001 azioni che si sono schiantate sul mercato azionario USA - Scenari Economici

Scenari Economici

Anti-ANGPTL3-FLD monoclonal antibody treatment ameliorates podocyte lesions through attenuating mitochondrial ... - Nature.com

Here's Why IMab Sponsored ADR (IMAB) is Poised for a Turnaround After Losing 26.8% in 4 Weeks - Yahoo Movies UK

Yahoo Movies UK

The Best- and Worst-Performing Stocks: Q3 2022 - Morningstar

Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket By Benzinga - Investing.com UK

Investing.com UK

Markets Brief: How High Can Mortgage Rates Go? - Morningstar

New 5-Star Stocks - Morningstar

HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace

10 biotechs to know in China - FiercePharma

I-Mab (IMAB) Stock Price, News & Analysis - NASDAQ - MarketBeat

Notch2 activation ameliorates nephrosis - Nature.com

$77.56

0.77%

$149.40

1.20%

$29.98

1.11%

$172.85

1.06%

$365.81

2.87%

$90.61

2.55%

Apri su Yahoo | Apri su Google | Aperto in Finviz